Drug Discovery News
Immune-Mediated Diseases & Inflammation Drug
Discovery World Summit To Be Held March 8-10 Baltimore, MD
1/9/2004
Source: Strategic Research Institute
The world inflammatory & immune disease drug discovery research
community -- will be convening in Baltimore, MD to attend, speak, and
exhibit at "Immune-Mediated Diseases & Inflammation Drug Discovery
World Summit," announces Strategic Research Institute.
This conference program progresses through three full days of 35
unique scientific presentations, seamlessly integrated, with the second
day adjoined by a keynote plenary session that will address the key
issues and complexity in finding new treatments for inflammatory and
immune diseases.
The Immune-Mediated Diseases/Anti-Inflammation Drug Discovery &
Development World Summit is the largest meeting of its kind and has
been organized to bring together the entire community of immunology
& inflammatory researchers for the first time, as they will review many
of their programs intended to generate next generation drugs.
Participants include: 3M PHARMACEUTICALS, ABBOTT
BIORESEARCH, ARCHEMIX CORP., ASTRAZENECA R&D,
ASTRAZENECA UK, ATHEROGENICS INC., BIOVATION
LTD., CELGENE CORPORATION, CELGENE SAN DIEGO,
CENTER FOR RHEUMATIC DISEASES, GLASGOW ROYAL
INFIRMARY, CENTOCOR, COLEY PHARMACEUTICAL
GmbH, DIREVO BIOTECH AG, ICOS CORPORATION,
IMPERIAL COLLEGE LONDON, INCYTE CORPORATION,
JOHNSON & JOHNSON PHARMACEUTICAL R&D, L.L.C., LA
JOLLA PHARMACEUTICAL COMPANY, LAKESHORE
MEDICAL CLINIC, MCMASTER UNIVERSITY, NATIONAL
INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,
NATIONAL PSORIASIS FOUNDATION, NEREUS
PHARMACEUTICALS, NOVARTIS GmbH, NOVOSOM AG,
NYU SCHOOL OF MEDICINE, PROTEIN DESIGN LABS,
PROVIDENT PRECLINICAL INC., TARGETED MOLECULES
CORPORATION, XENCOR.
Keynote addresses: Steven B. Abramson, M.D., NYU SCHOOL OF
MEDICINE; Peter J. Barnes, Ph.D., Ian Adcock, Ph.D., IMPERIAL
COLLEGE LONDON; Paul Garside, Ph.D., UNIVERSITY OF
GLASGOW; Jack Gauldie Ph.D., FRSC, MCMASTER
UNIVERSITY; Iain B. McInnes, MRCP, Ph.D., CENTRE FOR
RHEUMATIC DISEASES, GLASGOW ROYAL INFIRMARY.
To request the agenda in PDF, please contact Ed Drilon at
edrilon@srinstitute.com or 212-967-0095 x233. Include your fax
number, affiliation and mailing address.
To register for the exposition or inquire about sponsorship
opportunities please contact Mark Alexay at malexay@srinstitute.com.
To become a media partner please contact Cheryl Kahan Radhuber at
ckahan-radhuber@srinstitute.com.
CONTACT: Ed Drilon, +1-212-967-0095 ext. 233,
edrilon@srinstitute.com,or Mark Alexay, malexay@srinstitute.com, or
Cheryl Kahan Radhuber,ckahan-radhuber@srinstitute.com, all of
Strategic Research Institute
Web site: srinstitute.com |
